Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vyne Therapeutics Inc (VYNE)

Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vyne Therapeutics Inc 685 ROUTE 202/206 SUITE 301 BRIDGEWATER NJ 08807 USA

www.vynetherapeutics.com Employees: 10 P: 800-775-7936

Description:

VYNE Therapeutics Inc. focuses on developing and commercializing therapeutics for dermatology. The company's product pipeline consist FMX103 and FCD105 which are in clinical stage. VYNE Therapeutics Inc., formerly known as Menlo Therapeutics Inc., is based in Bridgewater, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 44,696
Enterprise Value, $K 14,026
Shares Outstanding, K 14,751
Annual Sales, $ 420 K
Annual Net Income, $ -28,450 K
Last Quarter Sales, $ 120 K
Last Quarter Net Income, $ -12,160 K
EBIT, $ -37,700 K
EBITDA, $ -37,960 K
60-Month Beta 1.32
% of Insider Shareholders 4.80%
% of Institutional Shareholders 83.78%
Float, K 14,043
% Float 95.20%
Short Volume Ratio 0.22

Growth:

1-Year Return -22.31%
3-Year Return -83.66%
5-Year Return -98.94%
5-Year Revenue Growth -96.05%
5-Year Earnings Growth 98.40%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 11/07/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -0.86
EPS Growth vs. Prev Qtr -31.82%
EPS Growth vs. Prev Year 84.32%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-18 on 02/13/23

VYNE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -43.73%
Return-on-Assets % -38.55%
Profit Margin % -6,773.81%
Debt/Equity 0.00
Price/Sales 100.89
Price/Cash Flow N/A
Price/Book 0.67
Book Value/Share 4.31
Interest Coverage -1.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar